DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y
Alpha Vantage · TradingView · · AI-summarised by FinFlash
DaVita (DVA) reported adjusted earnings per share of $3.82 in Q3 2026, surpassing Zacks' estimates by 1.1% and increasing 52.2% year over year. Revenues rose 4.6% to $3.58 billion, driven by strong Integrated Kidney Care (IKC) and international operations. The company also updated its 2026 guidance, narrowing adjusted operating income and raising IKC-adjusted operating income expectations.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.